S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

$41.57
+0.55 (+1.34%)
(As of 03/27/2024 ET)
Today's Range
$41.04
$41.57
50-Day Range
$40.72
$42.65
52-Week Range
$35.53
$43.20
Volume
29,703 shs
Average Volume
32,067 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.13%
Price Target
N/A
BME stock logo

About BlackRock Health Sciences Trust Stock (NYSE:BME)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BME Stock Price History

BME Stock News Headlines

Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
BME: Historically One Of The Best Times For Entry
Blackrock Health Sciences Trust's Dividend Analysis
Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
BME - BlackRock Health Sciences Trust
Blackrock Health Sciences Trust (NYSE: BME)
See More Headlines
Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/29 Dividend
2/14/2024
Dividend Payable
2/29/2024
Ex-Dividend for 3/28 Dividend
3/14/2024
Today
3/27/2024
Dividend Payable
3/28/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.41 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Charles Choon Sik Park (Age 57)
    Chief Compliance Officer and Anti-Money Laundering Officer
  • Mr. Thomas P. Callan C.F.A.
    Portfolio Manager
  • Mr. Kyle G. McClements C.F.A.
    Portfolio Manager
  • Dr. Erin Xie Ph.D. (Age 56)
    Portfolio Manager
  • Mr. Christopher M. Accettella
    Portfolio Manager
  • Mr. Jeffrey Gene Lee
    Portfolio Manager
  • Dr. Xiang Liu Ph.D.
    Portfolio Manager

BME Stock Analysis - Frequently Asked Questions

How have BME shares performed in 2024?

BlackRock Health Sciences Trust's stock was trading at $40.46 at the start of the year. Since then, BME stock has increased by 2.7% and is now trading at $41.57.
View the best growth stocks for 2024 here
.

Are investors shorting BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust saw a decline in short interest during the month of February. As of February 29th, there was short interest totaling 14,000 shares, a decline of 45.5% from the February 14th total of 25,700 shares. Based on an average daily trading volume, of 37,800 shares, the days-to-cover ratio is currently 0.4 days.
View BlackRock Health Sciences Trust's Short Interest
.

How often does BlackRock Health Sciences Trust pay dividends? What is the dividend yield for BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust announced a monthly dividend on Friday, March 1st. Shareholders of record on Friday, March 15th will be paid a dividend of $0.213 per share on Thursday, March 28th. This represents a $2.56 annualized dividend and a dividend yield of 6.15%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for BME
.

Is BlackRock Health Sciences Trust a good dividend stock?

BlackRock Health Sciences Trust (NYSE:BME) pays an annual dividend of $2.55 per share and currently has a dividend yield of 0.06%.
Read our dividend analysis for BME.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and Procter & Gamble (PG).

Who are BlackRock Health Sciences Trust's major shareholders?

BlackRock Health Sciences Trust's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Wells Fargo & Company MN (0.00%), Nova R Wealth Inc. (0.00%), 1607 Capital Partners LLC (0.00%), Royal Bank of Canada (0.00%), Cornerstone Advisory LLC (0.00%) and UBS Group AG (0.00%).
View institutional ownership trends
.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BME) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners